Iron oxide nanoparticles are important magnetic nanomaterials used in research areas such as biomedical imaging models, magnetic separation, targeted delivery studies, hyperthermia-related investigations, biosensing, and theranostic material development. Their usefulness depends not only on the iron oxide core but also on the condition of the nanoparticle surface. Poorly stabilized iron oxide nanoparticles may aggregate, settle quickly, lose dispersion uniformity, or interact unpredictably with biological and formulation media.

Surface conditioning is therefore an important early step in iron oxide nanoparticle research. Conditioning may involve washing, buffer exchange, p H-compatible dispersion, addition of stabilizing agents, polymer coating, ligand-compatible preparation, or other surface-modification approaches. The selected conditioning method can influence colloidal stability, apparent particle size, surface charge, compatibility with biological media, and downstream functionalization potential.

Manual conditioning of nanoparticle dispersions may vary from batch to batch because washing, mixing, sonication, temperature exposure, stabilizer addition, and waiting periods are often handled differently by different operators. Protoly can help organize the workflow into a defined sequence, while the NSL platform can support selected physical operations such as liquid dispensing, stirring, heating, waiting, sonication, illumination, camera documentation, exhaust operation, and environment recording.

The aim of this protocol is to prepare a conditioned iron oxide nanoparticle dispersion suitable for downstream theranostic model studies. The protocol does not claim therapeutic or diagnostic validation. Instead, it provides a structured preparation route that can be followed by external characterization and biological evaluation when required.

This protocol is important because iron oxide nanoparticle performance depends strongly on the surface condition of the particles. Even when the magnetic core remains the same, changes in stabilizer, coating chemistry, washing method, dispersion medium, sonication time, or storage condition can significantly affect aggregation, surface charge, magnetic response, biological interaction, and downstream application potential.

The Protoly-managed workflow provides a structured way to define the conditioning process. Instead of treating surface conditioning as an informal manual step, the method can be broken into controlled actions such as dilution, stabilizer addition, coating-agent addition, mixing, heating, waiting, optional sonication, and visual documentation. The NSL platform can support many of these physical actions through available hardware modules, while advanced characterization remains external.

A major advantage of this workflow is its flexibility. Different surface-conditioning approaches can be compared using the same base protocol. For example, one batch may be citrate-conditioned, another dextran-coated, another PEG-stabilized, and another chitosan-conditioned. The resulting dispersions can then be compared externally for hydrodynamic size, zeta potential, visible stability, magnetic response, and compatibility with model biological media.

For theranostic model studies, surface conditioning is especially relevant because a nanoparticle intended for imaging, targeting, hyperthermia, or drug-delivery research must remain stable in the chosen medium. Visible settling, aggregation, and poor resuspension can reduce the usefulness of the material and affect interpretation of downstream results. Automation-assisted preparation can improve repeatability by keeping addition volume, mixing time, heating duration, sonication duration, and waiting periods consistent between batches.

However, this protocol has defined limitations. It does not confirm that the nanoparticles are suitable for diagnostic imaging, therapeutic delivery, magnetic hyperthermia, or biological use. It also does not independently measure particle size, magnetic properties, surface chemistry, cytotoxicity, sterility, or cellular uptake. These must be evaluated separately using suitable external methods. The prepared dispersion should therefore be considered a conditioned research prototype, not a clinically validated theranostic formulation.

Overall, the protocol provides a useful bridge between nanoparticle preparation and advanced theranostic evaluation. It demonstrates how Protoly can manage a partially NSL-supported nanomaterial workflow while clearly separating automation-supported preparation from external analytical and biological validation.

This protocol presents an automation-assisted workflow for surface conditioning of iron oxide nanoparticles for theranostic model studies. Using Protoly and selected NSL modules, the workflow supports controlled dispensing, stirring, mild heating, waiting, optional sonication, chamber illumination, camera documentation, exhaust control, and environment recording.

The main value of the protocol is that it converts a manually variable nanoparticle conditioning process into a structured and documented workflow. It can support research-scale comparison of stabilizers, coating systems, dispersion media, sonication conditions, and conditioning times. The final output is a conditioned iron oxide nanoparticle dispersion that can be used for downstream offline characterization and model studies.

The protocol does not validate the material for clinical diagnosis, therapy, imaging, hyperthermia, or in vivo use. External testing such as particle size analysis, zeta potential, FTIR, XRD, magnetic characterization, microscopy, cytotoxicity testing, sterility assessment, and biological validation is required before any advanced biomedical application can be considered.